Home > Insider Trading > Filing (0001235802-22-000129)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401040	Diamedica Therapeutics Inc.	DMAC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1759822	Michael Randall Giuffre	301 Carlson Parkway, Suite 210 Minneapolis MN 55305		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Voting Common Shares, No Par Value Per Share	Acquisiton	2022-12-01	819	$1.19	178,272	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Voting Common Shares, No Par Value Per Share	25,573	Indirect	See footnote
Voting Common Shares, No Par Value Per Share	21,070	Indirect	By Spouse

Footnotes

Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 29,829 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 82,937 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually.
These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power.